Göknur Yildiz, Özge Turgay Yildirim, Şeyhmus Kaya, Fatih Alper Ayyildiz, Can Gökay Yildiz
{"title":"The Effect of Iron Deficiency Anemia on the Morphology–Voltage–P Wave Duration (MVP) Risk Score","authors":"Göknur Yildiz, Özge Turgay Yildirim, Şeyhmus Kaya, Fatih Alper Ayyildiz, Can Gökay Yildiz","doi":"10.1111/anec.70116","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Iron deficiency anemia (IDA) is a common global health issue affecting over two billion people and is associated with cardiovascular complications. Electrocardiographic (ECG) abnormalities may reflect cardiac involvement in IDA. The Morphology-Voltage-P wave Duration (MVP) score, which assesses P-wave duration, voltage, and morphology, is linked to atrial fibrillation (AF) risk. This study aimed to investigate the relationship between IDA and MVP score to evaluate its potential in cardiac risk assessment.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A prospective study was conducted between January 1 and June 30, 2024, at a tertiary hospital. It included 241 IDA patients and 204 healthy controls. All participants underwent ECG and echocardiography. MVP scores were calculated, and left atrial (LA) diameter and left ventricular ejection fraction (LVEF) were recorded.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>MVP scores were significantly higher in the IDA group compared to controls (<i>p</i> < 0.001). P-wave morphology and voltage were notably altered in IDA patients (<i>p</i> < 0.001). LA diameters were larger, and LVEF values were lower in the IDA group (<i>p</i> < 0.001). MVP scores positively correlated with LA size and negatively with LVEF. Additionally, IDA patients had higher heart rates and lower diastolic blood pressure (<i>p</i> < 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>IDA is associated with increased MVP scores, suggesting possible atrial remodeling and higher AF risk. The MVP score may serve as a non-invasive tool for cardiovascular risk stratification in IDA patients. Further research is needed to assess the impact of IDA treatment on ECG parameters and arrhythmia risk.</p>\n </section>\n </div>","PeriodicalId":8074,"journal":{"name":"Annals of Noninvasive Electrocardiology","volume":"30 6","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/anec.70116","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Noninvasive Electrocardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/anec.70116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Iron deficiency anemia (IDA) is a common global health issue affecting over two billion people and is associated with cardiovascular complications. Electrocardiographic (ECG) abnormalities may reflect cardiac involvement in IDA. The Morphology-Voltage-P wave Duration (MVP) score, which assesses P-wave duration, voltage, and morphology, is linked to atrial fibrillation (AF) risk. This study aimed to investigate the relationship between IDA and MVP score to evaluate its potential in cardiac risk assessment.
Methods
A prospective study was conducted between January 1 and June 30, 2024, at a tertiary hospital. It included 241 IDA patients and 204 healthy controls. All participants underwent ECG and echocardiography. MVP scores were calculated, and left atrial (LA) diameter and left ventricular ejection fraction (LVEF) were recorded.
Results
MVP scores were significantly higher in the IDA group compared to controls (p < 0.001). P-wave morphology and voltage were notably altered in IDA patients (p < 0.001). LA diameters were larger, and LVEF values were lower in the IDA group (p < 0.001). MVP scores positively correlated with LA size and negatively with LVEF. Additionally, IDA patients had higher heart rates and lower diastolic blood pressure (p < 0.001).
Conclusions
IDA is associated with increased MVP scores, suggesting possible atrial remodeling and higher AF risk. The MVP score may serve as a non-invasive tool for cardiovascular risk stratification in IDA patients. Further research is needed to assess the impact of IDA treatment on ECG parameters and arrhythmia risk.
期刊介绍:
The ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (A.N.E) is an online only journal that incorporates ongoing advances in the clinical application and technology of traditional and new ECG-based techniques in the diagnosis and treatment of cardiac patients.
ANE is the first journal in an evolving subspecialty that incorporates ongoing advances in the clinical application and technology of traditional and new ECG-based techniques in the diagnosis and treatment of cardiac patients. The publication includes topics related to 12-lead, exercise and high-resolution electrocardiography, arrhythmias, ischemia, repolarization phenomena, heart rate variability, circadian rhythms, bioengineering technology, signal-averaged ECGs, T-wave alternans and automatic external defibrillation.
ANE publishes peer-reviewed articles of interest to clinicians and researchers in the field of noninvasive electrocardiology. Original research, clinical studies, state-of-the-art reviews, case reports, technical notes, and letters to the editors will be published to meet future demands in this field.